Activist Client Engaged Capital Discloses 5.7% Medifast Stake

Firm News

The Wall Street Journal, Bloomberg and other media outlets reported on Engaged Capital’s public disclosure of a 5.7% stake in Medifast Inc., the weight loss program provider. Engaged Capital stated its belief that Medifast is undervalued, trading at roughly 40% discount to its peers in the weight-loss sector such as Nutrisystem Inc. and Weight Watchers International Inc. Engaged Capital revealed it has had discussions with Medifast’s management regarding improving the profitability of Medifast’s operations, accelerating growth in its core business, and the adoption of a disciplined approach to capital allocation with a focus on return on invested capital.  Engaged Capital said it may make proposals in the future concerning the company's capitalization, ownership structure, board structure or operations.  Steve Wolosky and Ryan Nebel represent Engaged Capital in connection with its investment in Medifast.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.